임상 검사 서비스 시장 : 검사 유형별, 세계 예측(2023-2032년)

Global Clinical Laboratory Services Market will register a 3.8% CAGR from 2023 to 2032 due to significant advancements in medical technology and the increasing establishment of laboratories globally. Innovations, particularly in diagnostic techniques and equipment, contribute to the market's growth, enhancing the precision and efficiency of clinical testing. As the demand for comprehensive healthcare services rises, the establishment of new laboratories will further support the market's expansion, catering to the evolving needs of healthcare systems globally and shaping the trajectory of clinical laboratory services.

Medical service providers are actively embracing innovation incorporating advanced technologies, and expanding their infrastructure by establishing cutting-edge laboratories. For instance, in 2023, Medi Linx Laboratory, a prominent medical service provider, inaugurated a state-of-the-art standalone laboratory in Quezon City. Tailored for hospitals, clinics, and individual patients, this advanced facility features cutting-edge equipment and technology, allowing Medi Linx to deliver swift, precise, and reliable clinical testing results. This expansion bolsters market size by elevating diagnostic capabilities and expanding operational capacity.

The clinical laboratory services industry is classified based on test type, service provider, and region.

The humor and tumor genetics segment will achieve remarkable market share by 2032, owing to the increasing demand for personalized healthcare solutions. As genetic diagnostics gain prominence, this segment becomes pivotal in unraveling disease predisposition and guiding tailored treatment strategies. Its emphasis on precision medicine positions it as a primary player, aligning with the evolving needs of diagnostic services and reflecting a crucial role in shaping the trajectory of clinical laboratory services within the healthcare landscape.

The standalone laboratory segment will garner notable gains through 2032, attributed to its autonomy and specialized focus. As healthcare demands advanced diagnostics, standalone laboratories offer specialized services catering to diverse medical needs. Their efficiency, accuracy, and ability to adapt to evolving technologies will position them as crucial contributors to the clinical laboratory services industry. With a growing emphasis on streamlined and specialized testing, the standalone laboratory segment will stand out as a key player in shaping the market's landscape.

Europe will grow at a noteworthy CAGR from 2023 to 2032, propelled by a robust healthcare infrastructure and increasing demand for diagnostic services. The region's well-established medical facilities and emphasis on preventive healthcare contribute to its prominence. As healthcare providers and laboratories strive to meet the rising demand for advanced diagnostic solutions, Europe will emerge as a pivotal contributor to the clinical laboratory services market, reflecting a commitment to delivering comprehensive and high-quality healthcare services.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Clinical laboratory services industry 360 degree synopsis, 2018 - 2032 (USD Billion)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Test type trends
  • 2.1.4 Service provider trends

Chapter 3 Clinical Laboratory Services Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Billion)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of targeted diseases
    • 3.2.1.2 Worldwide rising demand for early disease detection
    • 3.2.1.3 Introduction of innovative solutions
    • 3.2.1.4 Growing elderly population base in developed countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Presence of ambiguous regulatory framework
    • 3.2.2.2 Inadequate reimbursement
• 3.3 Growth potential analysis
  • 3.3.1 By test type
  • 3.3.2 By service provider
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Clinical Laboratory Services Market Estimates and Forecast, By Test Type, 2018-2032 (USD Billion)

• 5.1 Key trends, by test type
• 5.2 Humor & tumor genetics
• 5.3 Clinical chemistry
  • 5.3.1 Routine chemistry testing
  • 5.3.2 Specialized chemistry testing
  • 5.3.3 Therapeutic drug monitoring (TDM) testing
  • 5.3.4 Endocrinology chemistry testing
  • 5.3.5 Other clinical chemistry testing
• 5.4 Medical microbiology & cytology
• 5.5 Other esoteric tests

Chapter 6 Clinical Laboratory Services Market Estimates and Forecast, By Service Provider, 2018-2032 (USD Billion)

• 6.1 Key trends, by service provider
• 6.2 Hospital-based laboratories
• 6.3 Stand-alone laboratories
• 6.4 Clinic-based laboratories

Chapter 7 Clinical Laboratory Services Market Estimates and Forecast, By Region, 2018 - 2032 (USD Billion)

• 7.1 Key trends, by region
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Rest of Latin America
• 7.6 Middle East & Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 Rest of Middle East & Africa

Chapter 8 Company Profiles

• 8.1 Arup Laboratories Inc.
• 8.2 Sonic Healthcare
• 8.3 Neogenomics Laboratories, Inc. (Neogenomics, Inc.)
• 8.4 Opko Health, Inc. (Bioreference Laboratories, Inc.)
• 8.5 Laboratory Corporation of America Holdings (Labcorp)
• 8.6 Quest Diagnostics Inc.
• 8.7 Fresenius Medical Care (Spectra Laboratories)
• 8.8 Qiagen N.V.
• 8.9 Synlab International GmbH
• 8.10 Charles River Laboratories
• 8.11 Fullerton Healthcare Corporation Limited
• 8.12 LifeLabs
• 8.13 Eurofins Scientific